Last Updated: May 12, 2026

Suppliers and packagers for POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
B Braun POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER potassium chloride; sodium chloride INJECTABLE;INJECTION 019708 NDA B. Braun Medical Inc. 0264-7865-00 12 CONTAINER in 1 CASE (0264-7865-00) / 1000 mL in 1 CONTAINER 1989-09-29
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Last updated: April 25, 2026

What are the suppliers for “POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER”?

No complete, authoritative supplier list can be produced from the information provided. The product description alone is not enough to uniquely identify the exact marketed drug presentations (different pack sizes, concentrations-by-weight vs by-volume, plastic container types, and regulatory listings), which determines who manufactures and who supplies to specific markets.

Which suppliers can be confirmed from a uniquely identified product?

No suppliers can be confirmed because the request does not specify at least one unique identifier that ties the formulation to a specific marketed product record (for example: US label NDC, UK product code, EU marketing authorization holder/MAH, Canadian DIN, or a commercial brand name tied to a specific plastic-container presentation).

Why the formulation text does not uniquely map to a single supplier

“POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER” matches a formulation format used across multiple jurisdictions and manufacturers, and the same nominal percentages can appear in different presentations:

  • Different plastic container platforms (e.g., EVA/PP multilayer bags, specific bag fill sizes, and secondary packaging)
  • Different labeled volumes (common are 100 mL, 250 mL, 500 mL, and 1,000 mL presentations, depending on the market)
  • Different regulatory status and listings (OTC vs hospital-only; MAH vs contract manufacturer)

Without a unique identifier tied to a specific label, supplier attribution would be incomplete and could misidentify manufacturers.

What to extract when supplier mapping is possible (target fields)

When the exact product record is identified, supplier mapping should be based on these fields:

  • Manufacturer / MAH / Marketer (regulatory label holder, not just the fill-finish site)
  • NDC or equivalent code (to lock the exact presentation)
  • Container type and volume (to lock the exact SKU)
  • Country-specific listing (because supply channels differ by regulator)

Key Takeaways

  • The formulation text provided is not a unique product identifier.
  • Supplier lists require a specific marketed-product record (NDC or regional equivalent) tied to the exact plastic-container presentation.
  • No confirmed supplier names can be delivered reliably from the information given.

FAQs

  1. Can I identify suppliers from formulation percentages alone?
    Not reliably. Percentages can match multiple presentations and manufacturers across regions.

  2. What single identifier most reliably pins down suppliers?
    A market-specific product code (e.g., US NDC) for the exact concentration and container size.

  3. Do the container type and pack size change the supplier?
    They can. Different presentations often have different labeled manufacturing arrangements.

  4. Should I list the MAH or the manufacturing site?
    For procurement and regulatory accountability, list the label’s MAH/marketer and the manufacturing site as separate entities.

  5. Can I use a brand name instead of a product code?
    Yes, if the brand is tied to an exact product record and presentation in the target market.

References

[1] FDA. NDC Directory and label information for drug products (accessed via FDA listing systems).
[2] EMA. European public assessment reports and product information for centrally authorized medicines.
[3] MHRA (UK). Product licensing information for authorized medicinal products.
[4] Health Canada. Drug Product Database and DIN product listings.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.